For example, several genes associated with CCH syndromes are target of NOVA2‐mediated AS regulation (e.g., CASK and DCC) and CCH is present in 33% of patients (Saito et al., 2016). The gene discussed is DCC; the disease is columnar cell hyperplasia of the breast.